Reduce infections of HPV types prevented by the vaccine in young adults — Data - Healthy People 2030

National Status: Baseline only

Most Recent Data:
15.1 percent (2013-16)

National Target:
8.7 percent ^¶

Desired Direction:
Decrease desired

National Baseline:
15.1 percent of persons aged 20 to 34 years were positive for at least 1 HPV type prevented by the 9-valent vaccine in 2013-16

Locality

Demographic Group

From (year)

To (year)

Show disparities data

Show confidence interval (CI) View CI in the chart by hovering over a data point.

Show standard error (SE) View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Reference rate:

¶: The target applies to national level estimates.

#: Some years of data are not available for the data selections.

#: Standard errors and confidence intervals are not available for this population group.

◊: Unless otherwise noted, data represent "percent, 20–34 years"

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.